StockMarketWire.com - Oncology and rare disease focused Midatech Pharma said it had received funding of €6.6m from the Spanish government.
The funding would support the company' manufacturing facility in Bilbao.
It brought the total public financing available for the project to up to €8.5m, including previous grant and loan amounts recently approved by the Basque regional government.
The total manufacturing cost of the project was currently estimated at about €16m, subject to finalisation of a manufacturing strategy.
At 1:49pm: [LON:MTPH] Midatech Pharma Plc share price was +1p at 6.25p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.